Financhill
Sell
42

CCEL Quote, Financials, Valuation and Earnings

Last price:
$5.08
Seasonality move :
6.88%
Day range:
$5.09 - $5.23
52-week range:
$4.75 - $9.43
Dividend yield:
12.77%
P/E ratio:
509.00x
P/S ratio:
1.30x
P/B ratio:
--
Volume:
2.4K
Avg. volume:
9.8K
1-year change:
-37.7%
Market cap:
$41.1M
Revenue:
$32M
EPS (TTM):
$0.01

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Upside
    No price target exists because of limited analyst coverage.
  • Price Target Downside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Cryo-Cell International has 66.99% upside to fair value with a price target of $8.50 per share.

CCEL vs. S&P 500

  • Over the past 5 trading days, Cryo-Cell International has underperformed the S&P 500 by -1.54% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Cryo-Cell International does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Cryo-Cell International has grown year-over-year revenues for 13 quarters straight. In the most recent quarter Cryo-Cell International reported revenues of $8M.

Earnings Growth

  • Cryo-Cell International earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Cryo-Cell International reported earnings per share of $0.03.
Enterprise value:
50.7M
EV / Invested capital:
--
Price / LTM sales:
1.30x
EV / EBIT:
10.91x
EV / Revenue:
1.58x
PEG ratio (5yr expected):
--
EV / Free cash flow:
12.32x
Price / Operating cash flow:
10.12x
Enterprise value / EBITDA:
8.67x
Gross Profit (TTM):
$24.3M
Return On Assets:
0.2%
Net Income Margin (TTM):
0.4%
Return On Equity:
--
Return On Invested Capital:
122.88%
Operating Margin:
13.25%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-02-28 2024-02-28 2025-02-28 2024-02-28 2025-02-28
Income Statement
Revenue $30.9M -- $32.1M -- $8M
Gross Profit $22.1M -- $24.3M -- $6M
Operating Income $4.6M -- $4M -- $1.1M
EBITDA $6.8M -- $5.8M -- $1.4M
Diluted EPS $0.32 -- $0.01 -- $0.03
Period Ending 2021-02-28 2022-02-28 2023-02-28 2024-02-28 2025-02-28
Balance Sheet
Current Assets $18.7M $9.7M $10.6M -- $12.5M
Total Assets $105.3M $54.8M $66.1M -- $64.4M
Current Liabilities $29.8M $16.4M $18.9M -- $21.7M
Total Liabilities $107M $50.6M $66.8M -- $79M
Total Equity -$1.7M $4.3M -$687.5K -- -$14.7M
Total Debt $4.2M $1.1M $10.5M -- $13M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-02-28 2024-02-28 2025-02-28 2024-02-28 2025-02-28
Cash Flow Statement
Cash Flow Operations $8.7M -- $7.3M -- $954.1K
Cash From Investing -$10.4M -- -$4.8M -- -$287.5K
Cash From Financing $947K -- -$2.5M -- -$1M
Free Cash Flow -$3.2M -- $4.1M -- $892K
CCEL
Sector
Market Cap
$41.1M
$33.4M
Price % of 52-Week High
53.98%
46.84%
Dividend Yield
12.77%
0%
Shareholder Yield
7.29%
-0.6%
1-Year Price Total Return
-37.7%
-37.4%
Beta (5-Year)
0.670
0.632
Dividend yield:
12.77%
Annualized payout:
$0.25
Payout ratio:
3139.7%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $5.17
200-day SMA
Sell
Level $6.74
Bollinger Bands (100)
Sell
Level 5.12 - 7.36
Chaikin Money Flow
Buy
Level 4.5M
20-day SMA
Buy
Level $5.05
Relative Strength Index (RSI14)
Sell
Level 48.00
ADX Line
Buy
Level 14
Williams %R
Neutral
Level -63.0876
50-day SMA
Sell
Level $5.26
MACD (12, 26)
Sell
Level -0.01
25-day Aroon Oscillator
Buy
Level 52
On Balance Volume
Neutral
Level 13.2M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.3952)
Sell
CA Score (Annual)
Level (-3.1115)
Buy
Beneish M-Score (Annual)
Level (-2.7422)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-6.6059)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (8)
Sell
Fundamental Score
Level (3)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Stock Forecast FAQ

In the current month, CCEL has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CCEL average analyst price target in the past 3 months is $8.50.

  • Where Will Cryo-Cell International Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Cryo-Cell International share price will rise to $8.50 per share over the next 12 months.

  • What Do Analysts Say About Cryo-Cell International?

    Analysts are divided on their view about Cryo-Cell International share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cryo-Cell International is a Sell and believe this share price will drop from its current level to $8.50.

  • What Is Cryo-Cell International's Price Target?

    The price target for Cryo-Cell International over the next 1-year time period is forecast to be $8.50 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is CCEL A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Cryo-Cell International is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of CCEL?

    You can purchase shares of Cryo-Cell International via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cryo-Cell International shares.

  • What Is The Cryo-Cell International Share Price Today?

    Cryo-Cell International was last trading at $5.08 per share. This represents the most recent stock quote for Cryo-Cell International. Yesterday, Cryo-Cell International closed at $5.09 per share.

  • How To Buy Cryo-Cell International Stock Online?

    In order to purchase Cryo-Cell International stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Palantir Stock Overvalued?
Is Palantir Stock Overvalued?

By every traditional yardstick, including a price‑to‑sales well above 100,…

Is Gamestop’s Bitcoin Strategy Going To Succeed?
Is Gamestop’s Bitcoin Strategy Going To Succeed?

When GameStop (NYSE: GME) announced in Q1 that its board had…

How High Will Roku Stock Go?
How High Will Roku Stock Go?

Streaming software and hardware maker Roku (NASDAQ:ROKU) has seen its…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
11
VEON alert for Jun 14

VEON [VEON] is down 18.57% over the past day.

Buy
74
DAVE alert for Jun 14

Dave [DAVE] is down 12.68% over the past day.

Buy
54
DAR alert for Jun 14

Darling Ingredients [DAR] is up 9.12% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock